Status:

RECRUITING

Exploratory Biomarker Analysis of Neoadjuvant Chemoimmunotherapy Followed by Pulmonary Resection in Stage II-III Non-Small Cell Lung Cancer

Lead Sponsor:

Yonsei University

Conditions:

Clinical Stage II to III Non-Small Cell Lung Cancer

Eligibility:

All Genders

19+ years

Brief Summary

1. To explore tissue-based biomarkers to select patients who do not respond to neoadjuvant immunotherapy (non-responders) at the point of diagnosis 2. To explore blood-based non-invasive biomarkers to...

Detailed Description

1. Construction of a neoadjuvant chemoimmuntherapy cohort of resectable stage 2-3 lung cancer patients and acquisition of clinical-pathological-radiological data. 2. Plasma from individual patient wil...

Eligibility Criteria

Inclusion

  • Histologically proven clinical stage II-III lung cancer patients
  • No driver mutations (EGFR mutation and ALK alteration)
  • Whole body performance (ECOG) 0-1
  • Those over 19 years of age
  • Subject who submitted Informed consent form

Exclusion

  • Under 19 years of age
  • If there is a history of causing infection or other serious medical problems that impair the patient's function and make it difficult to comply with the study protocol.
  • Patients for whom the investigator determines that the patient should not participate in the clinical trial because the patient is judged to be unable to comply with the clinical trial procedures and requirements (a person lacking medical capacity)
  • Other patients (pregnant women, etc.) determined by the clinical trial director to be unsuitable for this clinical trial.

Key Trial Info

Start Date :

August 7 2024

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

June 30 2029

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06907160

Start Date

August 7 2024

End Date

June 30 2029

Last Update

April 2 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Thoracic and Cardiovascular Surgery, Severance Hospital, Yonsei University College of Medicine

Seoul, South Korea